News

In the new drug application (NDA), the company included results from two Phase III trials, one pivotal trial, and a supportive trial of Zentase in pediatric patients. Also

The open-label dose escalation trial in patients with progressive metastatic malignancies is currently ongoing at the H Lee Moffitt Cancer Center, Tampa, Florida, and at the M D

The clinical trial is a double-blind, placebo-controlled, multiple-dose trial lasting for four weeks followed by a voluntary open label period of up to eight additional weeks. The company

The patents were licensed from Southern Illinois University (SIU). The research underlying the patents was a collaboration of psychology faculty at SIU Carbondale and physiology and neurology faculty

Under this agreement, Emmaus will commercialize NutreStore, which is approved by the FDA for use in combination with human growth hormone as a treatment for short bowel syndrome

The patent claims the use of DermTech’s ‘tape stripping’ technology for the purposes of detecting, staging and monitoring melanoma. The methods claimed in the patent focus on the

MedaSorb has initiated its first clinical site and will be enrolling up to a total of nine sites for the European study. MedaSorb estimates the study will take

Under the terms of the agreement, PerkinElmer will acquire Pediatrix’s metabolic screening laboratory and its StepOne newborn screening product that is capable of analyzing more than 50 inherited

The drug master file (DMF) is a submission to the FDA that will be used to provide confidential detailed information about facilities, processes, or articles used in the